Arcus Biosciences (RCUS) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free RCUS Stock Alerts $15.70 +0.20 (+1.29%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArcus Biosciences to Participate in the Bank of America Healthcare Conference 2024businesswire.com - May 2 at 4:05 PMPromising Outlook for Arcus Biosciences Anchored by Strong Clinical Trials and Strategic Market Positioningmarkets.businessinsider.com - May 2 at 12:56 AMArcus Biosciences (RCUS) to Release Quarterly Earnings on Wednesdaymarketbeat.com - May 1 at 7:24 AMArcus Biosciences, Inc. (NYSE:RCUS) Short Interest Down 17.1% in Aprilmarketbeat.com - April 28 at 9:18 AMArcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meetingbusinesswire.com - April 24 at 4:00 PMArcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Updatebusinesswire.com - April 23 at 4:05 PMEli Lilly subsidiary ends lucrative collaboration with Durham biotechbizjournals.com - April 18 at 7:57 AMPrecision BioSciences: Strategic Independence and Promising Gene Editing Pipeline Fuel Buy Ratingmarkets.businessinsider.com - April 18 at 1:45 AMBuy Rating Affirmed for Precision BioSciences Amid Strong Gene Editing Prospects and Upcoming Milestonesmarkets.businessinsider.com - April 17 at 8:44 PMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - April 9 at 4:35 PMVanguard Group Inc. Acquires 61,040 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - April 6 at 4:15 AMArcus Biosciences (NYSE:RCUS) Shares Down 2.8% marketbeat.com - April 3 at 1:57 PMInvestors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%finance.yahoo.com - April 1 at 9:26 AMInsider Selling: Arcus Biosciences, Inc. (NYSE:RCUS) COO Sells 11,551 Shares of Stockinsidertrades.com - March 30 at 7:35 AMInsider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - March 29 at 7:52 PMArcus Biosciences, Inc. (NYSE:RCUS) COO Jennifer Jarrett Sells 11,551 Sharesmarketbeat.com - March 29 at 6:40 PMXilio and Gilead partner up for IL-12 therapeutic developmentmsn.com - March 29 at 2:09 AMArcus Biosciences (NYSE:RCUS) Trading Up 7.6%marketbeat.com - March 27 at 3:24 PMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - March 26 at 4:35 PMNavigating 5 Analyst Ratings For Arcus Biosciencesmarkets.businessinsider.com - March 25 at 4:20 PMTruist Financial Reiterates Buy Rating for Arcus Biosciences (NYSE:RCUS)marketbeat.com - March 25 at 1:11 PMArcus Biosciences COO sells over $240k in company stockinvesting.com - March 22 at 8:58 PMInsider Selling: Arcus Biosciences, Inc. (NYSE:RCUS) COO Sells 13,449 Shares of Stockinsidertrades.com - March 21 at 9:59 AMInsider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - March 20 at 10:12 PMArcus Biosciences (NYSE:RCUS) Shares Down 5.6% marketbeat.com - March 18 at 12:44 PMTraders Purchase Large Volume of Arcus Biosciences Call Options (NYSE:RCUS)marketbeat.com - March 13 at 11:20 AMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - March 11 at 4:35 PMArcus Biosciences (NYSE:RCUS) Trading 6.6% Higher marketbeat.com - March 11 at 3:17 PMTrexquant Investment LP Purchases Shares of 78,637 Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - March 5 at 7:52 AMArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 2 at 1:59 AMInsider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - February 29 at 3:28 AMArcus Biosciences to Participate in Two Upcoming Investor Conferencesbusinesswire.com - February 28 at 4:05 PMFmr LLC Has $85.80 Million Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - February 28 at 5:28 AMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - February 27 at 4:35 PM38,224 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Acquired by Dark Forest Capital Management LPmarketbeat.com - February 27 at 6:20 AMEvaluating Arcus Biosciences’ Casdatifan Potential and Strategic Position in RCC Treatment Landscapemarkets.businessinsider.com - February 26 at 8:15 AMArcus Biosciences, Inc. (NYSE:RCUS) to Post FY2028 Earnings of $1.87 Per Share, Wedbush Forecastsmarketbeat.com - February 23 at 8:21 AMGilead downgraded at Truist on cancer strategymsn.com - February 22 at 7:11 PMAnalysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR)markets.businessinsider.com - February 22 at 2:10 PMArcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 22 at 2:10 PMArcus Biosciences: Trading At Large Discount To Recent Gilead Investmentseekingalpha.com - February 22 at 11:13 AMArcus Biosciences (NYSE:RCUS) Trading 12.1% Higher After Strong Earningsmarketbeat.com - February 22 at 10:23 AMArcus Biosciences' (RCUS) "Outperform" Rating Reaffirmed at Wedbushmarketbeat.com - February 22 at 8:51 AMArcus Biosciences GAAP EPS of -$1.08 misses by $0.06, revenue of $31M beats by $2.7Mmsn.com - February 21 at 7:52 PMArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Updatefinance.yahoo.com - February 21 at 7:52 PMArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Updatebusinesswire.com - February 21 at 4:05 PMRCUS Mar 2024 30.000 callfinance.yahoo.com - February 18 at 4:03 PMRCUS Mar 2024 20.000 putfinance.yahoo.com - February 18 at 4:03 PMRCUS Mar 2024 10.000 callca.finance.yahoo.com - February 17 at 8:01 PMRCUS Mar 2024 12.500 callca.finance.yahoo.com - February 17 at 9:59 AM Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. RCUS Media Mentions By Week RCUS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼0.320.42▲Average Medical News Sentiment RCUS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼33▲RCUS Articles Average Week Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANI Pharmaceuticals News Today Kura Oncology News Today Morphic News Today Akero Therapeutics News Today Day One Biopharmaceuticals News Today Gyre Therapeutics News Today Edgewise Therapeutics News Today Ardelyx News Today Zai Lab News Today Ironwood Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
